Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
A Japanese company's attempt to land a spacecraft on the moon has apparently failed. Flight controllers lost contact Wednesday with the lander after it descended from lunar orbit, aiming for the dusty surface.
The Supreme Court on Friday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
Peter Krull, a partner and director of sustainable investing at Prime Capital Investment Advisors company Earth Equity Advisors, joined Cheddar News to give some tips on green investments.
The Supreme Court is facing a self-imposed Friday night deadline to decide whether women’s access to a widely used abortion pill will stay unchanged until a legal challenge to its Food and Drug Administration approval is resolved.
Sam Rose, an activist with Truth Initiative and a former e-cigarette user, joined Cheddar News to speak about his experience with purchasing flavored tobacco products and his group's message to other teens to stay wary.
Under a cloudless sky, 20,000 eclipse chasers crowded a tiny outpost to watch a rare solar eclipse plunge part of Australia's northwest coast into brief midday darkness Thursday while temporarily cooling the tropical heat.
